BP |
GO:0007166~cell surface receptor signalling pathway |
3 |
CD86, FCGR2A, MS4A7 |
0.0091958 |
BP |
GO:0002224~toll‐like receptor signalling pathway |
2 |
TLR8, CTSS |
0.01244988 |
BP |
GO:0032753~positive regulation of interleukin‐4 production |
2 |
CD86, FCER1G |
0.01244988 |
BP |
GO:0032703~negative regulation of interleukin‐2 production |
2 |
LAPTM5, VSIG4 |
0.01290833 |
BP |
GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II |
2 |
FCER1G, CTSS |
0.01474024 |
BP |
GO:0006955~immune response |
3 |
CD86, CTSS, C1QC |
0.02089994 |
BP |
GO:0042130~negative regulation of T cell proliferation |
2 |
CD86, VSIG4 |
0.022492168 |
BP |
GO:0045087~innate immune response |
3 |
FCER1G, TLR8, C1QC |
0.032249129 |
BP |
GO:1901224~positive regulation of NIK/NF‐kappaB signalling |
2 |
CD86, LAPTM5 |
0.032443573 |
BP |
GO:0016064~immunoglobulin mediated immune response |
2 |
FCER1G, TLR8 |
0.039176889 |
MF |
GO:0019864~IgG binding |
2 |
FCGR2A, FCER1G |
0.005792506 |
CC |
GO:0016021~integral component of membrane |
10 |
CD86, SLC7A7, FCGR2A, FCER1G, MS4A7, LAPTM5, TLR8, C1ORF162, VSIG4, MS4A4A |
1.84E‐04 |
CC |
GO:0005886~plasma membrane |
8 |
CD86, SLC7A7, FCGR2A, FCER1G, MS4A7, LAPTM5, TLR8, MS4A4A |
0.009202711 |
CC |
GO:0009897~external side of plasma membrane |
3 |
CD86, FCER1G, TLR8 |
0.02557098 |
CC |
GO:0005887~integral component of plasma membrane |
4 |
SLC7A7, FCGR2A, FCER1G, LAPTM5 |
0.036563874 |
KEGG |
hsa05322:Systemic lupus erythematosus |
3 |
CD86, FCGR2A, C1QC |
0.00683036 |
KEGG |
hsa05152:Tuberculosis |
3 |
FCGR2A, FCER1G, CTSS |
0.011572895 |